background


Product Information:

MLi-2

MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease.

Cat. No.: EX-A4118    Purity: >98%
MLi-2
For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
100mg650In-stock
250mg985In-stock
500mg1485In-stock
1g2385In-stock
5g9150In-stock
10g14640Inquire


CAS No.1627091-47-7
Purity>98%
FormulaC21H25N5O2
Mol Weight379.4555
Appearancesolid powder
SolubilitySoluble in DMSO
Shelf Life>2 years if stored properly
StoragePowder -20℃ 3 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  

[1]. Fell MJ, et al. MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. J Pharmacol Exp Ther. 2015 Dec;355(3):397-409.

CoACoA of MLi-2
Smiles:C[C@@](C1)([H])O[C@](C)([H])CN1C2=CC(C3=NNC4=CC=C(OC5(C)CC5)C=C43)=NC=N2

KEYWORDS: buy MLi-2 | MLi-2 supplier | purchase | cost | manufacturer | order | distributor | buy 1627091-47-7 | 1627091-47-7 supplier